1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies

The 24 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. Risk-adverse private equity, venture capital and other investors continue to hesitate on backing companies...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0